MA27007A1 - Nouveaux derives de [3,4-a:3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. - Google Patents
Nouveaux derives de [3,4-a:3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.Info
- Publication number
- MA27007A1 MA27007A1 MA27327A MA27327A MA27007A1 MA 27007 A1 MA27007 A1 MA 27007A1 MA 27327 A MA27327 A MA 27327A MA 27327 A MA27327 A MA 27327A MA 27007 A1 MA27007 A1 MA 27007A1
- Authority
- MA
- Morocco
- Prior art keywords
- group
- pharmaceutical compositions
- preparation process
- description
- new
- Prior art date
Links
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical class C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27007A1 true MA27007A1 (fr) | 2004-12-20 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27327A MA27007A1 (fr) | 2002-10-16 | 2003-09-26 | Nouveaux derives de [3,4-a:3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (es) |
| EP (1) | EP1411057B1 (es) |
| JP (1) | JP2004277404A (es) |
| KR (1) | KR100502250B1 (es) |
| CN (1) | CN1241925C (es) |
| AR (1) | AR041618A1 (es) |
| AT (1) | ATE294181T1 (es) |
| AU (1) | AU2003254746A1 (es) |
| BR (1) | BR0304575A (es) |
| CA (1) | CA2443585A1 (es) |
| DE (1) | DE60300571T2 (es) |
| DK (1) | DK1411057T3 (es) |
| EA (1) | EA007250B1 (es) |
| ES (1) | ES2240927T3 (es) |
| FR (1) | FR2845996A1 (es) |
| HK (1) | HK1063321A1 (es) |
| MA (1) | MA27007A1 (es) |
| MX (1) | MXPA03009362A (es) |
| MY (1) | MY134620A (es) |
| NO (1) | NO20034614L (es) |
| NZ (1) | NZ528902A (es) |
| PL (1) | PL362885A1 (es) |
| PT (1) | PT1411057E (es) |
| SG (1) | SG131765A1 (es) |
| SI (1) | SI1411057T1 (es) |
| ZA (1) | ZA200308053B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| WO2008109591A1 (en) | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| EP3105225A1 (en) | 2014-02-12 | 2016-12-21 | iTeos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| MX2016015005A (es) * | 2014-05-15 | 2017-09-28 | Iteos Therapeutics | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1. |
| CA2979616C (en) | 2015-03-17 | 2020-04-28 | Pfizer Inc. | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法 |
| WO2017025868A1 (en) | 2015-08-10 | 2017-02-16 | Pfizer Inc. | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質ｂｅ―１３７９３ｃ |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 EP EP03292545A patent/EP1411057B1/fr not_active Expired - Lifetime
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active IP Right Cessation
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
-
2004
- 2004-08-13 HK HK04106087A patent/HK1063321A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL362885A1 (en) | 2004-04-19 |
| SG131765A1 (en) | 2007-05-28 |
| DK1411057T3 (da) | 2005-08-29 |
| CA2443585A1 (fr) | 2004-04-16 |
| ZA200308053B (en) | 2004-07-08 |
| PT1411057E (pt) | 2005-08-31 |
| US7151108B2 (en) | 2006-12-19 |
| AU2003254746A1 (en) | 2004-05-06 |
| EP1411057A1 (fr) | 2004-04-21 |
| SI1411057T1 (es) | 2005-08-31 |
| AR041618A1 (es) | 2005-05-26 |
| DE60300571T2 (de) | 2006-02-23 |
| EA007250B1 (ru) | 2006-08-25 |
| MY134620A (en) | 2007-12-31 |
| EA200301020A1 (ru) | 2004-04-29 |
| DE60300571D1 (de) | 2005-06-02 |
| HK1063321A1 (en) | 2004-12-24 |
| KR20040034472A (ko) | 2004-04-28 |
| ES2240927T3 (es) | 2005-10-16 |
| ATE294181T1 (de) | 2005-05-15 |
| NO20034614L (no) | 2004-04-19 |
| MXPA03009362A (es) | 2004-04-28 |
| FR2845996A1 (fr) | 2004-04-23 |
| CN1496989A (zh) | 2004-05-19 |
| NZ528902A (en) | 2004-09-24 |
| KR100502250B1 (ko) | 2005-07-20 |
| EP1411057B1 (fr) | 2005-04-27 |
| JP2004277404A (ja) | 2004-10-07 |
| BR0304575A (pt) | 2004-07-20 |
| CN1241925C (zh) | 2006-02-15 |
| NO20034614D0 (no) | 2003-10-15 |
| US20040077672A1 (en) | 2004-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| May et al. | Selenium-based antihypertensives: rationale and potential | |
| MA30596B1 (fr) | 18-methyl-19-nor-androst-4-en-17,17-spiroethers (18-methyl-19-nor-20-spirox-4-en-3-one) et preparations pharmaceutiques les contenant. | |
| MA26727A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant | |
| FR2365588A1 (fr) | Procede de preparation d'androstanones-17 | |
| BE903128A (fr) | Derives de benzimidazole procede pour leur preparation et agents anti-ulceres en contenant | |
| EP0385850A3 (fr) | Nouveaux dérivés de benzimidazoles et azabenzimidazoles, leurs procédés de préparation, intermédiaires de synthèse, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et les ulcères duodénaux | |
| CA2633057A1 (fr) | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique | |
| MA27007A1 (fr) | Nouveaux derives de [3,4-a:3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| CH639653A5 (fr) | Aminothiazoles et composition pharmaceutique les contenant. | |
| CA2270086A1 (fr) | Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CA2013324A1 (fr) | Pteridin-4 (3h)-ones, procedes de preparation et medicaments les contenant | |
| BE904796A (fr) | Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant. | |
| IE851555L (en) | Organo selenium compounds. | |
| Prakash et al. | Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats after Oral Administration of a Mixture of14C-and 3H-Labeled Ziprasidone | |
| JPH01503063A (ja) | 抗炎症組成物 | |
| JPS63250341A (ja) | 芳香族アルデヒドおよびその誘導体 | |
| MA27104A1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA27341A1 (fr) | NOUVEAUX DERIVES DE PYRROLO[3,4-c]CARBAZOLE ET DE PYRIDO[2,3-b]PYRROLO[3,4-e]INDOLE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT . | |
| CA2323720A1 (fr) | Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA28325A1 (fr) | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| JPH0649678B2 (ja) | メルカプタン誘導体およびその製造方法 | |
| MA27963A1 (fr) | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| CA2289599A1 (fr) | Composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CH661661A5 (fr) | Agent antineoplasique. | |
| MA27340A1 (fr) | NOUVEAUX DERIVES DE [1,4]BENZODIOXINO[2,3-e]ISOINDOLE SUBSTITUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT . |